Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.09.2023 | Case report

Nivolumab

Various toxicities : 12 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Higashiyama RI, et al. Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients. Journal of Cancer Research and Clinical Oncology 149: 3185-3191, 2023. Available from: URL: http://doi.org/10.1007/s00432-022-04205-9 Higashiyama RI, et al. Non-specific symptoms as a prodrome of immune-related adverse events in patients with non-small cell lung cancer receiving nivolumab: a consecutive analysis of 200 patients. Journal of Cancer Research and Clinical Oncology 149: 3185-3191, 2023. Available from: URL: http://​doi.​org/​10.​1007/​s00432-022-04205-9
Metadaten
Titel
Nivolumab
Various toxicities : 12 case reports
Publikationsdatum
01.09.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-45958-x

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Abemaciclib

Case report

Fluorouracil

Case report

Multiple drugs